Novel Orally Disintegrating Tablets Produced Using a High-Pressure Carbon Dioxides Process
نویسندگان
چکیده
منابع مشابه
Risperidone Orally Disintegrating Tablets
---------------------------------------------------RECENT MAJOR CHANGES------------------------------------------------- Indications and Usage, Schizophrenia/Adolescents (1.1) 08/2007 Indications and Usage, Bipolar Mania/Pediatrics (1.2) 08/2007 Dosage and Administration, Schizophrenia/Adolescents (2.1) 08/2007 Dosage and Administration, Bipolar Mania/Pediatrics (2.2) 08/2007 -----------------...
متن کاملOrally Disintegrating Tablets: An Overview
Article history: Received on: 06/01/2014 Revised on: 22/01/2014 Accepted on: 12/02/2014 Available online: 27/02/2014 Orally disintegrating tablets (ODTs) have greatly increased dosage forms which have remarkable impact on the patient compliance especially for the pediatric, geriatric and psychiatric patients with deglutition disorders. Several technologies either conventional or patented based ...
متن کامل(rizatriptan Benzoate) Orally Disintegrating Tablets
Its empirical formula is C15H19N5•C7H6O2, representing a molecular weight of the free base of 269.4. Rizatriptan benzoate is a white to off-white, crystalline solid that is soluble in water at about 42 mg per mL (expressed as free base) at 25°C. MAXALT Tablets and MAXALT-MLT* Orally Disintegrating Tablets are available for oral administration in strengths of 5 and 10 mg (corresponding to 7.265 ...
متن کاملHigh-dose olanzapine orally disintegrating tablets for treatment-resistant psychosis.
Sir: Olanzapine is a thienobenzodiazepine antipsychotic that has a broad in vitro affinity for several receptors, including serotonergic, cholinergic, dopaminergic, and adrenergic receptors. Olanzapine is approved for treatment of psychoses at doses up to 20 mg/day. New research suggests benefits of higher doses of olanzapine. Anecdotal case reports highlight the benefits of olanzapine at 50 mg...
متن کاملTRADENAME (Citalopram HBr) Orally Disintegrating Tablets
Antidepressants increased the risk of suicidal thinking and behavior (suicidality) in shortterm studies in children and adolescents with Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of [Insert established name] or any other antidepressant in a child or adolescent must balance this risk with the clinical need. Patients who are started on therapy sho...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chemical and Pharmaceutical Bulletin
سال: 2018
ISSN: 0009-2363,1347-5223
DOI: 10.1248/cpb.c18-00220